Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Phreesia, Inc. (NYSE: PHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents help investors analyze how Phreesia reports its financial performance, material events and key agreements related to its healthcare technology and patient activation business.
Phreesia’s filings include Current Reports on Form 8-K that describe significant developments such as quarterly financial results, material definitive agreements and acquisitions. For example, the company has filed 8-Ks covering its fiscal quarter results, the Agreement and Plan of Merger to acquire AccessOne Parent Holdings, Inc., and the completion of that acquisition, which made AccessOne a wholly owned subsidiary. Other 8-Ks detail the bridge loan credit agreement, amendments to its credit facility with Capital One and the voting results of its annual meeting of stockholders.
Through this page, users can also locate annual reports on Form 10-K and quarterly reports on Form 10-Q (when available in the broader filing set), which typically contain segment information for subscription and related services, payment processing fees and network solutions, along with discussions of non-GAAP measures such as Adjusted EBITDA. Proxy materials and governance-related filings provide additional context on board elections, auditor ratification and executive compensation votes.
Stock Titan enhances these filings with AI-powered summaries that highlight key points, explain complex sections and surface items such as new debt obligations, acquisition terms or changes to credit agreements. Real-time updates from EDGAR, combined with simplified explanations, make it easier to track Phreesia’s regulatory history, capital structure and major corporate actions without reading every page of each filing.
Phreesia, Inc. (PHR) has filed a Form 144 indicating that shareholder Yvonne Hui intends to sell 307 common shares, worth about $8,371.83, through Fidelity Brokerage on or about 15 July 2025. With 59,504,269 shares outstanding, the planned sale represents roughly 0.0005% of the company’s float.
The filing also discloses that the same seller disposed of 4,208 shares over the past three months in six separate transactions, generating gross proceeds of approximately $104,610. The 307 shares being registered for sale were acquired on 11 July 2025 via restricted-stock vesting and constitute compensation-related stock.
The notice includes the standard certification that the seller is unaware of any non-public adverse information about Phreesia. Given the very small size relative to total shares outstanding and the routine nature of Rule 144 sales, this event is unlikely to be materially impactful for investors.